openPR Logo
Press release

US Breast Cancer Drug Market, Price, Dosage and Clinical Pipeline Insight 2025

04-24-2019 05:43 AM CET | Health & Medicine

Press release from: KuicK Research

US Breast Cancer Drug Market, Price, Dosage and Clinical

"US Breast Cancer Drug Market, Price, Dosage and Clinical Pipeline Insight 2025" Report Highlights:

US Breast Cancer Drug Market Opportunity: US$ 20 Billion
US Breast Cancer Drug Clinical Pipeline by Company, Phase, Drug Class and Patient Segment
US Breast Cancer Marketed Drugs: 42 Drugs
US Breast Cancer Drug Clinical Pipeline: 317 Drugs
Dosage and Pricing Insight for Preventive and Treatment Drugs
US Breast Cancer Drug Market Dynamics

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

Download Report: https://www.kuickresearch.com/report-us-breast-cancer-drug-market,-price,-dosage-and-clinical-pipeline-insight-2025.php

Report Table of Contents

1. US - Cancer Incidence and Prevalence

2. US Breast Cancer Market Landscape
2.1 Incidence and Prevalence
2.2 Diagnosis of Breast Cancer

3. US Breast Cancer Drug Market
3.1 Overview US Breast Cancer Drug Market
3.2 Diagnosis and Screening Market Scenario
3.3 US Breast Cancer Clinical Pipeline Overview (Phase, Drug Class, Company, Patient Segment)

4. Forward Looking Developments in Breast Cancer Drug Market
4.1 ER Positive Breast Cancer
4.1.1 CDK4/6 Inhibitors
4.1.2 PI3K Inhibitors
4.1.3 Crizotinib for Lobular Breast Cancer
4.2 HER2-Positive Breast Cancer
4.2.1 Palbociclib and Herceptin (Spain)
4.2.2 Tecentriq - FDA Approval for Breast Cancer
4.3 Triple Negative Breast Cancer
4.3.1 Atezolizumab and Nab-Paclitaxel
4.3.2 Sacituzumab Govitecan
4.3.3 Carboplatin and Docetaxel

5. US - Dosage and Pricing Insight for Drugs Approved for the Prevention of Breast Cancer
5.1 Raloxifene Hydrochloride
5.2 Elvista
5.3 Tamoxifen Citrate

6. US - Dosage and Pricing Insight for Drugs Approved for the Treatment of Breast Cancer
6.1 Abemaciclib
6.2 Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
6.3 Ado-Trastuzumab Emtansine
6.4 Afinitor (Everolimus)
6.5 Anastrozole
6.6 Aromasin (Exemestane)
6.7 Xeloda (Capecitabine)
6.8 Docetaxel (Docetaxel Anhydrous)
6.9 Doxorubicin Hydrochloride
6.10 Ellence (Epirubicin Hydrochloride)
6.11 Fluorouracil
6.12 Taxol (Paclitaxel)
6.13 Methotrexate
6.14 Cyclophosphamide
7. US Breast Cancer Drug Market Dynamics
7.1 Market Drivers
7.1.1 Increasing Incidence of Breast Cancer
7.1.2 Research and Development for Novel Drugs
7.1.3 Increase in Healthcare Expenditure and Funding
7.1.4 Increasing Breast Cancer Screening Programs
7.1.5 Rising Consumption of Tobacco and Alcohol
7.2 US Breast Cancer Drug Market Challenges
7.2.1 Pricing Pressure Experienced by the Innovators
7.2.2 High Cost associated with Drug Development and Clinical Trials
7.2.3 Obstacles to the Incorporation of New Therapies for Breast Cancer

8. US - Breast Cancer Drug Market Forecast
8.1 Future Potential of US Breast Cancer Drug Market
8.2 Opportunities for Forthcoming Drug Classes

9. US - Breast Cancer Drug Clinical Pipeline by Company and Phase
9.1 Research
9.2 Preclinical
9.3 Clinical
9.4 Phase-I
9.5 Phase-I/II
9.6 Phase-II
9.7 Phase-II/III
9.8 Phase-III
9.9 Preregistration
9.10 Registered

10. US - Marketed Breast Cancer Drug Clinical Insight by Company
10.1 Afinitor
10.2 LYNPARZA
10.3 Abraxane
10.4 Verzenio
10.5 Kisqali
10.6 Lymphoseek
10.7 Kadcyla
10.8 Ibrance
10.9 Nerlynx
10.10 Soltamox
10.11 Tykerb
10.12 Zoladex
10.13 Omnitarg, Perjeta
10.14 Halaven
10.15 Taxotere
10.16 Other( 27 Drugs Profiles)

11. Competitive Landscape
11.1 Agilent Technologies
11.2 AstraZeneca
11.3 Bayer HealthCare Pharmaceuticals
11.4 Bristol-Myers Squibb
11.5 Eisai Co Ltd
11.6 Eli Lilly
11.7 Novartis
11.8 Onyx Pharmaceuticals
11.9 Orion
11.10 Perrigo
11.11 Pfizer
11.12 Roche

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Breast Cancer Drug Market, Price, Dosage and Clinical Pipeline Insight 2025 here

News-ID: 1714926 • Views:

More Releases from KuicK Research

Global Breast Cancer Immunotherapy Market and Clinical Trials Forecast 2028
Global Breast Cancer Immunotherapy Market and Clinical Trials Forecast 2028
Global Breast Cancer Immunotherapy Market and Clinical Trials Forecast 2028 Report Highlights: * Global Breast Cancer Immunotherapy Market Opportunity > USD 60 Billion By 2028 * Global Market and Regional Market Trends * Global Market Forecast Till 2028 * Approved Drugs Yearly and Quarterly Sales Insight 2019 - 2023 * Approved Drugs Global and Regional Sales Insight 2019 - 2023 * Approved Drug Pricing and Dosage Analysis * Comprehensive Insight On 250 Drugs In Clinical Trials By
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Global Cancer Vaccine Market, Vaccine Price, Dosage, Sales and Clinical Trials Outlook 2029
Global Cancer Vaccine Market, Vaccine Price, Dosage, Sales and Clinical Trials O …
Global Cancer Vaccine Market, Vaccine Price, Dosage, Sales and Clinical Trials Outlook 2029 Report Highlights: * Global Cancer Vaccine Market Opportunity : > USD 20 Billion By 2029 * Cancer Vaccine Market Regional Trends Insight: 10 Countries * Cancer Vaccine Market Trends Insight By Indication: 10 Indications * Insight On Cancer Vaccine In Clinical Trials: > 400 Vaccines * Insight On Cancer Vaccine Commercially available in Market: > 15 Vaccines * Cancer Vaccines Clinical Trials By
Global Bcr Abl Tyrosine Kinase Inhibitor Drug Market, Drug Price, Sales and Clinical Trials Insight 2029
Global Bcr Abl Tyrosine Kinase Inhibitor Drug Market, Drug Price, Sales and Clin …
Global Bcr Abl Tyrosine Kinase Inhibitor Drug Market, Drug Price, Sales and Clinical Trials Insight 2029 Report Highlights: * Global Bcr Abl Inhibitor Drug Market Opportunity: > USD 8 Billion Bcr Abl Inhibitor Drug Market Global and Regional Analysis * Approved Drugs Sales Insight (2019 - Q1'2023) * Approved Drugs Dosage, Patent and Price Insight * Bcr Abl Inhibitors Drugs Clinical Trials By Company, Indication and Phase: > 20 Drugs * Clinical Insight On Approved

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top